Evidence Synthesis
Tornotpharma Sees Strong Shift in Financials, with Gross Margin Accelerating to 75.98%, up from 21.76%.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 15 Sept 2026, 04:29
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
Tornotpharma Sees Strong Shift in Financials, with Gross Margin Accelerating to 75.98%, up from 21.76%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 75.98 % | 21.76 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 21.76 % | 13.87 | ▲ |
| REVENUE_GROWTH_YOY | 54.8 % | -8.2 | ▲ |
| EPS_ACTUAL | 17.748 INR | 19.001 | ▼ |
| EPS_SURPRISE_PERCENT | 0.016 % | 0.018 | ▼ |
| PRICE_CHANGE_PERCENT | 0.72 % | — | - |
| DAILY_VOLUME | 2,63,114 shares | 5,59,867 | ▼ |
| CLOSE_PRICE | 4,965.5 INR | 4,930 | ▲ |
| NEWS_SENTIMENT_SCORE | 0.75 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 7 count | 15 | ▼ |
| TARGET_PRICE_PREMIUM | 9.37 % | — | - |